RESTASIS® IS
DIFFERENT FROM
ARTIFICIAL TEARS
RESTASIS® and RESTASIS MultiDose® are not artificial tears. They are prescription eye drops. Artificial tears are over-the-counter lubricants that help moisten the eyes and provide temporary symptom relief, but they do not increase the eyes' ability to produce their own tears.
Unlike artificial tears, RESTASIS® treats the underlying cause of a type of Chronic Dry Eye by reducing inflammation and increasing the eyes’ ability to produce tears.
You can still use artificial tears for temporary relief as needed, but leave 15 minutes in between artificial tear drops and RESTASIS®. With consistent use of RESTASIS®, you may gradually rely less on artificial tears.
READY FOR MORE?
Learn how RESTASIS® can help treat a type of Chronic Dry Eye.
RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.
The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch FDA Goverment Website
, or call
1-800-FDA-1088.
Click here for full Product Information for
RESTASIS® and
RESTASIS MultiDose® .
APPROVED USE
RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.
IMPORTANT SAFETY INFORMATION
Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.
The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit
www.fda.gov/medwatch FDA Goverment Website, or call
1-800-FDA-1088.
Click here for full Product Information for
RESTASIS® and
RESTASIS MultiDose® .